Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

NCT02844933 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Insys Therapeutics filed Chapter 11 and terminated all studies.

Conditions

Prader-Willi Syndrome

Interventions

DRUG: Cannabidiol
DRUG: Placebo

Sponsor

Radius Pharmaceuticals, Inc.